See leaflet
See Risk Management Plan
Postep®
Indications
Postep®
erlotinib
Indications
- Non-small cell lung cancer.
- Pancreatic cancer.
Presentations
- 100 mg x 30 tablets
- 150 mg x 30 tablets
- 100 mg x 30 tablets
- 150 mg x 30 tablets